Tobias Sejbaek

University of Southern Denmark

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Nasrin Asgari

Professor

University of Southern Denmark

DENMARK

View details

Finn Sellebjerg

Professor

Copenhagen University Hospital

DENMARK

View details

Helle Hvilsted Nielsen

University of Southern Denmark

DENMARK

View details

Zsolt Illes

Professor

DENMARK

View details

Justin Yehuda Garber

Clinical Senior Lecturer

University of Sydney

AUSTRALIA

View details

Peter Vestergaard Rasmussen

Associate professor

Aarhus University

DENMARK

View details

Keld-Erik Byg

University of Southern Denmark

DENMARK

View details

Melinda Magyari

Associate professor

University of Copenhagen

DENMARK

View details

Mengliang Zhang

University of Southern Denmark

DENMARK

View details

Ulrik Dalgas

Aarhus University

DENMARK

View details

Svend Geertsen

Københavns Universitet

DENMARK

View details

Lars G Hvid

Aarhus University

DENMARK

View details

Izanne Roos

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tobias Sejbaek

Research Interests

Explore related searches

Contact this professor

Articles (14)

A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy

Increased retinal thickness in sarcoidosis patients with ocular system involvement visualized with optical coherence tomography: a cross-sectional study

Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate

Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study

Extended interval dosing with ocrelizumab in multiple sclerosis.

High temperature requirement A1 and macrophage migration inhibitory factor in the cerebrospinal fluid; a potential marker of conversion from relapsing-remitting to secondary progressive multiple sclerosis

Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients—a longitudinal cohort study

Study protocol

Patterns and predictors of multiple sclerosis phenotype transition

Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial.

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.

Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study

Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses

Progressive multifocal leukoencephalopathy in a patient with multiple myeloma

Collaborators (13)

Nasrin Asgari

Finn Sellebjerg

Helle Hvilsted Nielsen

Zsolt Illes

Justin Yehuda Garber

Peter Vestergaard Rasmussen

Keld-Erik Byg

Melinda Magyari

Mengliang Zhang

Ulrik Dalgas

Svend Geertsen

Lars G Hvid

Izanne Roos

Make your next move.